Abstract PS12-02: Safety and efficacy of an alternative schedule of palbociclib (PAL) in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) and the utility of serum thymidine kinase 1 (sTK1) activity in predicting PAL response

MLA

Katherine Clifton, et al. “Abstract PS12-02: Safety and Efficacy of an Alternative Schedule of Palbociclib (PAL) in Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) and the Utility of Serum Thymidine Kinase 1 (STK1) Activity in Predicting PAL Response.” Cancer Research, vol. 81, Feb. 2021, pp. PS12-02. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ca0ddb24816e0844591e1875bf880d6a&authtype=sso&custid=ns315887.

APA

Katherine Clifton, Jingqin Luo, Foluso O. Ademuyiwa, Lindsay L. Peterson, Caron Rigden, Mathew Cherian, Cynthia X. Ma, Anna Roshal, Mattias Bergqvist, Katherine N. Weilbaecher, Leonel Hernandez-Aya, Rama Suresh, Shana Thomas, Ashley Frith, Timothy Reardon, Pavan Kumar Tandra, Tracy Summa, & Jairam Krishnamurthy. (2021). Abstract PS12-02: Safety and efficacy of an alternative schedule of palbociclib (PAL) in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) and the utility of serum thymidine kinase 1 (sTK1) activity in predicting PAL response. Cancer Research, 81, PS12-02.

Chicago

Katherine Clifton, Jingqin Luo, Foluso O. Ademuyiwa, Lindsay L. Peterson, Caron Rigden, Mathew Cherian, Cynthia X. Ma, et al. 2021. “Abstract PS12-02: Safety and Efficacy of an Alternative Schedule of Palbociclib (PAL) in Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) and the Utility of Serum Thymidine Kinase 1 (STK1) Activity in Predicting PAL Response.” Cancer Research 81 (February): PS12-02. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ca0ddb24816e0844591e1875bf880d6a&authtype=sso&custid=ns315887.